Effects of Adenosine and a Selective A2A Adenosine Receptor Agonist on Hemodynamic and Thallium-201 and Technetium-99m-SestaMIBI Biodistribution and Kinetics

JACC: Cardiovascular Imaging

Volumn 2, Issue 10, 2009, Pages 1198-1208

  Mekkaoui, Choukri ^a   Jadbabaie, Farid ^a   Dione, Donald P ^a   Meoli, David F ^a   Purushothaman, Kailasnath ^a   Belardinelli, Luiz ^b   Sinusas, Albert J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CV THERAPEUTICS INC   (United States)

Author keywords

adenosine; biodistribution; myocardial perfusion imaging; regadenoson; tracer kinetics

Indexed keywords

ADENOSINE; ADENOSINE A2 RECEPTOR AGONIST; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; REGADENOSON; THALLIUM 201; TRACER;

ADULT ANIMAL; ANIMAL EXPERIMENT; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; EX VIVO STUDY; HEART HEMODYNAMICS; HEART MUSCLE BLOOD FLOW; KINETICS; NONHUMAN; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STENOSIS; VASODILATATION;

ACUTE DISEASE; ADENOSINE; ANIMALS; BLOOD FLOW VELOCITY; CHRONIC DISEASE; CORONARY CIRCULATION; CORONARY STENOSIS; DISEASE MODELS, ANIMAL; DOGS; HYPEREMIA; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; METABOLIC CLEARANCE RATE; MYOCARDIAL PERFUSION IMAGING; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PURINES; PYRAZOLES; RADIOPHARMACEUTICALS; RECEPTOR, ADENOSINE A2A; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS;

EID: 70349775786     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2009.06.013     Document Type: Article

References (25)

1. Canby R.C., Silber S., and Pohost G.M. Relations of the myocardial imaging agents 99mTc-MIBI and 201T1 to myocardial blood flow in a canine model of myocardial ischemic insult. Circulation 81 (1990) 289-296
2. Sinusas A.J., Watson D.D., Cannon Jr. J.M., and Beller G.A. Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxyisobutyl isonitrile and thallium-201. J Am Coll Cardiol 14 (1989) 1785-1793
3. Wackers F.J., Berman D.S., Maddahi J., et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 30 (1989) 301-311
4. Calnon D.A., Glover D.K., Beller G.A., et al. Effects of dobutamine stress on myocardial blood flow, 99mTc sestamibi uptake, and systolic wall thickening in the presence of coronary artery stenoses: implications for dobutamine stress testing. Circulation 96 (1997) 2353-2360
5. Candell-Riera J., Santana-Boado C., Castell-Conesa J., et al. Simultaneous dipyridamole/maximal subjective exercise with 99mTc-MIBI SPECT: improved diagnostic yield in coronary artery disease. J Am Coll Cardiol 29 (1997) 531-536
6. Cramer M.J., Verzijlbergen J.F., Van der Wall E.E., et al. Head-to-head comparison between technetium-99m-sestamibi and thallium-201 tomographic imaging for the detection of coronary artery disease using combined dipyridamole-exercise stress. Coron Artery Dis 5 (1994) 787-791
7. Marwick T., Willemart B., D'Hondt A.M., et al. Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography. Circulation 87 (1993) 345-354
8. Santos-Ocampo C.D., Herman S.D., Travin M.I., et al. Comparison of exercise, dipyridamole, and adenosine by use of technetium 99m sestamibi tomographic imaging. J Nucl Cardiol 1 (1994) 57-64
9. Glover D.K., Ruiz M., Edwards N.C., et al. Comparison between 201Tl and 99mTc sestamibi uptake during adenosine-induced vasodilation as a function of coronary stenosis severity. Circulation 91 (1995) 813-820
10. Zhao G., Linke A., Xu X., et al. Comparative profile of vasodilation by CVT-3146, a novel A2A receptor agonist, and adenosine in conscious dogs. J Pharmacol Exp Ther 307 (2003) 182-189
11. Trochu J.N., Zhao G., Post H., et al. Selective A2A adenosine receptor agonist as a coronary vasodilator in conscious dogs: potential for use in myocardial perfusion imaging. J Cardiovasc Pharmacol 41 (2003) 132-139
12. Cerqueira M.D., Nguyen P., Staehr P., Underwood S.R., and Iskandrian A.E. Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results. J Am Coll Cardiol Img 1 (2008) 307-316
13. Hendel R.C., Bateman T.M., Cerqueira M.D., et al. Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol 46 (2005) 2069-2075
14. Iskandrian A.E., Bateman T.M., Belardinelli L., et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol 14 (2007) 645-658
15. Leaker B.R., O'Connor B., Hansel T.T., et al. Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial. J Nucl Cardiol 15 (2008) 329-336
16. Thomas G.S., Tammelin B.R., Schiffman G.L., et al. Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial). J Nucl Cardiol 15 (2008) 319-328
17. Gao Z., Li Z., Baker S.P., et al. Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists. J Pharmacol Exp Ther 298 (2001) 209-218
18. Lieu H.D., Shryock J.C., von Mering G.O., et al. Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans. J Nucl Cardiol 14 (2007) 514-520
19. Liu Y.H., Sinusas A.J., DeMan P., Zaret B.L., and Wackers F.J. Quantification of SPECT myocardial perfusion images: methodology and validation of the Yale-CQ method. J Nucl Cardiol 6 (1999) 190-204
20. Liu Y.H., Sinusas A.J., Shi C.Q., et al. Quantification of technetium 99m-labeled sestamibi single-photon emission computed tomography based on mean counts improves accuracy for assessment of relative regional myocardial blood flow: experimental validation in a canine model. J Nucl Cardiol 3 (1996) 312-320
21. Glover D.K., Ruiz M., Takehana K., et al. Pharmacological stress myocardial perfusion imaging with the potent and selective A(2A) adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection. Circulation 104 (2001) 1181-1187
22. Hickey R.F., Sybert P.E., Verrier E.D., and Cason B.A. Effects of halothane, enflurane, and isoflurane on coronary blood flow autoregulation and coronary vascular reserve in the canine heart. Anesthesiology 68 (1988) 21-30
23. Bahlman S.H., Eger II E.I., Smith N.T., et al. The cardiovascular effects of nitrous oxide-halothane anesthesia in man. Anesthesiology 35 (1971) 274-285
24. Vatner S.F., and Smith N.T. Effects of halothane on left ventricular function and distribution of regional blood flow in dogs and primates. Circ Res 34 (1974) 155-167
25. Uren N.G., Melin J.A., De Bruyne B., Wijns W., Baudhuin T., and Camici P.G. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 330 (1994) 1782-1788